SPAR Web Site

Articles

2008 ACR/ARHP Conference
Join us in San Francisco, California for the ACR/ARHP Annual Scientific Meeting October 24-29, 2008. Click here for more information on SPAR events at ACR.

Renew Your Membership Today!
It is time to renew your membership for the 2008-2009 membership year. You can renew on-line or download a printable membership application by clicking on the Join tab.

Beta Testers Needed
ARHP is looking for people in the field of Rheumatology to test the Modules which have been developed by the steering committee. Click here for more information on Beta Testing and ways to get involved.

1. Special Announcement about COX-2 NSAIDS and traditional NSAIDS. December 23, 2004.

2. Effect of Maximal Daily Doses of Acetaminophen on the liver of alcoholic patients; A randomized, Double-blind, Placebo- controlled trial. Kuffner, EK, et al. Arch Intern Med 161:2247-52, Oct 8, 2001.

3. Pain Reduction at Venipuncture in Newborns: Oral glucose compared with local anesthetic cream. Gradin, M et al. Pediatrics, 110(6): 1053-57, Dec 2002.

4. A Physician Assistant Rheumatology Fellowship. Department of Veterans Affairs, Dallas, Texas. R. Hooker. April 2004.

5. Cyclobenzaprine With Ibuprofen Versus Ibuprofen Alone in Acute Myofascial Strain: A randomized, double-blind clinical trial. Turturro, MA, et al. Ann Emerg Med 41: 818-826, June 2003.

6. Are selective COX-2 inhibitors superior to traditional non- steroidal anti-inflammatory drugs? Juni P, et al. BMJ USA 2: 520- 2, Sept 2002 and BMJ 324: 1287-8, June 1,2002.

7. A randomized, clinical trial comparing oral celecoxib 200mg, celecoxib 400mg and ibuprofen 600mg for acute pain. Salo, OF, et al. Acad Emerg Med 10: 22-30, Jan 2003.

8. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: A randomized controlled trial. Smidt, N, et al, Lancet 359(9307): 657, Feb 23, 2002.

9. Time to abandon the "tendonitis" myth: Painful, overuse tendon" conditions have a non-inflammatory pathology. Khan KM, et al. BMJ 324: 626-7, March 16, 2002.

10. AFPPA News Release. Contact: Rose Phillips, AFPPA administrator, (877) 890-0181, afppa@afppa.org, www.afppa.org.

11. The COX-2 inhibitors: Are they really as good as they are cracked up to be? Gastrointestinal toxicity with Celocoxib vs. Nonsteroidal anti-inflammatory drugs for osteoarthritis and Rheumatoid arthritis. The CLASS Study. Silverstein FE., et al. JAMA 284(10): 1247-1255.

12. Safety and efficacy of S-Adenosylmethionine (SAME) for osteoarthritis: A meta-analysis. Soeken KL, et al. Jour Fam Pract 51(6): 425-430, May 2002.

13. Consumption of NSAID's and the Development of Congestive Heart Failure in Elderly Patients: An Under recognized Public Health Problem. Page, J. and Henry, D. Arch Intern Mod 160: 777-784, Mar 27, 2000.

14. Severity of knee pain does not predict a better response to an anti-inflammatory does of ibuprofen than to analgesic therapy in patients with osteoarthritis. Bradley, JD, et al. J Rheumatol 28: 1073-6, 2001.

15. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee. A randomized trial. Geba, GP, et al. JAMA 287(l): 64-71, January 2, 2002.

16. Risk of Cardiovascular Events associated with selective COX-2 Inhibitors. Mukherjee, D. et al. JAMA 286 (8): 954-959, August 22/29, 2001.

17. Cycicoxygenase inhibitors and the antiplatelet effects of aspirin. Catelia- Lawson, F., et al. NEJM 345 (25): 1809-1817, December 20, 2001.

18. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and naproxen in patients with rheumatoid arthritis. (The VIGOR Trial) Bombradier C., et al. NEJM, Nov. 23, 2000, Vol 343, (21), 1520-1528.

19. Physician Assistants are needed In Rheumatology. By: Jama Shoemaker, November 3, 2002